";s:4:"text";s:5226:" eCollection 2019.McArthur JG, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J, Nguyen P, Parachikova A, Abdulla F, Vercellotti GM, Hermine O, Edwards D, Ribeil JA, Belcher JD, Maciel TT.Haematologica. eCollection 2018. Hydroxyurea is a chronic medication for a chronic disease similar to medications people with Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life.Castro O, Nouraie M, Oneal P. Hydroxycarbamide Treatment in Sickle Cell Disease: Estimates of Possible
Epub 2003 Nov 20.J Blood Med.
Although teratogenic effects of hydroxyurea were reported in …
These side effects may go away during treatment as your body adjusts to the medicine. 2019 Jan;41(1):56-63. doi: 10.1097/MPH.0000000000001257.Front Chem. In numerous studies in both children and adults with sickle cell anemia, hydroxyurea treatment has been associated with fewer painful crises, fewer acute chest syndrome (lung complication) events, reduction in the need for transfusion, and reduction in the need for hospitalization.
2020 Mar;105(3):623-631. doi: 10.3324/haematol.2018.213462. Learn more.
It only works if you take it as directed. Ⓒ 2020 About, Inc. (Dotdash) — All rights reserved What Patients Should Consider Treatment With Hydroxyurea? Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Based on the doses used in sickle cell anemia, the side effects are relatively mild.
COVID-19 is an emerging, rapidly evolving situation. Verywell Health uses cookies to provide you with a great user experience. Hydroxyurea is a prototypic therapeutic option; it can be administered with minimal side effects, has a relatively wide therapeutic window, and has mechanisms of action that address pathophysiologic pathways of sickling, vaso-occlusion, hemolysis, and organ damage. Hydroxyurea (Droxia®; Hydrea®) is used to treat sickle cell disease. Hydroxyurea therapy offers promise for ameliorating the clinical course of children with sickle cell disease (SCD). According to a study published in 2014 looking specifically at patients with Hair loss, mouth sores, and increased risk of infection associated with chemotherapy are rarely seen. Based on the doses used in sickle cell anemia, the side effects are relatively mild.
2004 Mar 15;103(6):2039-45. doi: 10.1182/blood-2003-07-2475. In sickle cell anemia, hydroxyurea helps the body produce more fetal hemoglobin (Hb F). The introduction of hydroxyurea treatment with its reduction in morbidity and mortality, associated decreased medical costs, and restored well being should lead to further patient benefits. Hydroxyurea therapy offers promise for ameliorating the clinical course of children with sickle cell disease (SCD). Elsevier Science Because of this side effect, your physician will monitor your counts closely with
Newborn babies with sickle cell disease do not have complications in the first few months of life because fetal hemoglobin prevents the red blood cell from sickling. Historically, this has been a huge concern. Although clinical trials are underway to address long-term issues, hydroxyurea remains an effective but underutilized therapy for SCD.
Some side effects may occur that usually do not need medical attention. Hydroxyurea can decrease white blood cells, hemoglobin, and platelets.
By using Verywell Health, you accept our Hematol Oncol Clin North Am. Name must be less than 100 characters The patients initially treated with hydroxyurea had conditions that increased their risk of malignancy (cancer) but because they developed cancer while on hydroxurea therapy it was attributed to the medication. Like all drugs, it does have some side effects, and you need regular blood test monitoring. Unable to load your collection due to an error These round red blood cells are able to flow through blood vessels smoothly. Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our Medically reviewed by Anita C. Chandrasekaran, MD, MPH Please enable it to take advantage of the complete set of features! Hair loss, mouth sores, and increased risk of infection associated with chemotherapy are rarely seen. This increase in fetal hemoglobin helps keep your red blood cell round instead of sickled. Hydroxyurea is a class D medication indicating there appears to be a risk to developing fetus. Hydroxyurea also increases your Background and Aim: It is well known that hydroxyurea impacts on clinical and hematologic indices in sickle cell disease (SCD), we aimed to evaluate the effect of hydoxyurea on clinical and hematological improvement of Omani sickle cell disease pateints. Hydroxyurea can decrease white blood cells, hemoglobin, and platelets.